There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for Outset Medical Inc (OM) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.03, or -0.70%, to $4.24. The Outset Medical Inc has recorded 913,144 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed New Data Insights Unveiled at ASN Kidney Week 2023 Point to the Impact of the Tablo® Hemodialysis System on Equitable Kidney Care.
As a NASDAQ listed company, OM falls under the Healthcare sector while operating within the Medical Devices industry segment. At the end of the last regular session, the stock closed at $4.27 and fluctuated between $4.4639 as its day high and $4.2150 as its day low. The current market capitalization of Outset Medical Inc is $212.60M. A total of 1.3 million shares were traded on the day, compared to an average of 1.12M shares.
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, OM has seen 0 BUY and 8 SELL insider trades, representing the acquisition of 0 and the disposition of 9,062 shares. Over the last 12 months, there were 55 BUYs and 85 SELLs from insiders. Insiders purchased 833,559 shares during that period but sold 413,060.
In the most recent transaction, Ahmed Nabeel sold 545 shares of OM for 13.61 per share on Sep 01. After the transaction, the Chief Financial Officer now owns 89,171 company shares. In a previous transaction on Aug 16, Trigg Leslie sold 3,028 shares at 15.10 per share. OM shares that Chair and CEO owns now total 406,461.
Among the insiders who sold shares, Ahmed Nabeel disposed of 1,565 shares on Aug 16 at a per-share price of $15.10. This resulted in the Chief Financial Officer holding 89,171 shares of OM after the transaction. In another insider transaction, Brottem John L. sold 1,364 shares at $15.10 per share on Aug 16. Company shares held by the General Counsel now total 57,581.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for OM in the last 3 months, the mean price target is $14.20 with high estimates of $26.00 and low estimates of $3.00. In terms of 52-week highs and lows, OM has a high of $30.55 and a low of $2.90.
As of this writing, OM has an earnings estimate of -$0.67 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of -$0.57 per share and a lower estimate of -$0.72. The company reported an EPS of -$0.72 in the last quarter, which was 2.70% higher than expectations of -$0.74.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. OM’s latest balance sheet shows that the firm has $339.49M in Cash & Short Term Investments as of fiscal 2021. There were $37.81M in debt and $51.70M in liabilities at the time. Its Book Value Per Share was $3.69, while its Total Shareholder’s Equity was $374.08M.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for OM is Buy with a score of 3.57.